Effects of SR 141716A after acute or chronic cannabinoid administration in dogs
- 6 October 1998
- journal article
- Published by Elsevier
- Vol. 357 (2-3) , 139-148
- https://doi.org/10.1016/s0014-2999(98)00558-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brainEuropean Journal of Pharmacology, 1997
- Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United StatesDrug and Alcohol Dependence, 1997
- (R)-methanandamide, but not anadamide, substitutes for Δ–9-THC in a drug-discrimination procedure.Experimental and Clinical Psychopharmacology, 1997
- Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716AEuropean Journal of Pharmacology, 1995
- Effects of anandamide on cannabinoid receptors in rat brain membranesBiochemical Pharmacology, 1994
- Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodentsPharmacology Biochemistry and Behavior, 1993
- Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonistBiochemical Pharmacology, 1993
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Clinical Relevance of Cannabis Tolerance and DependenceThe Journal of Clinical Pharmacology, 1981